Elevated circulating levels of GDF15 have been shown to contribute to weight loss, muscle wasting, and impaired tolerance to treatment, all of which may negatively affect overall survival, independent of tumor burden [38,39,40,41,42]. The gene discussed is GDF15; the disease is neoplasm.